UV/Visible Spectroscopy Market Growth and Key Industry Players 2019 Analysis and Forecast

The UV/Visible Spectroscopy Market is poised to reach USD 1,163.2 Million, growing at a CAGR of 4.3 % during the forecast period, analyzes and studies the major market drivers, restraints/challenges, and opportunities.

Growing opportunities in emerging nations, development of micro volume sampling-capable instruments, investments into the field of molecular diagnostics and growth of biobanking are likely to provide growth opportunities to the global UV/visible spectroscopy market. However, the dearth of skilled professionals and longevity of instruments is likely to restrain the growth of this market.

Major Growth Drivers:

  • Applications of UV/Visible Spectroscopy in Environmental Screening
  • Growing Use of UV/Visible Spectroscopy in the Pharmaceuticals & Biotechnology Industry
  • Technological Advancement
  • Increasing Need for Food Analysis

Browse 80 market data tables and 43 figures spread through 150 pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=243898303

uv-visible-spectroscopy-market

Market Segmentation in Depth:

Based on instrument type, the market is segmented into single-beam systems, dual-beam systems, array-based systems and handheld systems. The single-beam systems segment is estimated to account for the major share of the UV/visible spectroscopy market. These instruments are routinely used analytical instruments in clinical examination, medicine, petrochemicals, biochemistry, biotechnology, quality control, and environmental protection as they are simple and economical.

Based on application, the market is segmented into academic applications and industrial applications. The industrial applications segment is estimated to account for the major share of the UV/visible spectroscopy market. The instruments are used in various industrial fields such as life science R&D, production, quality assurance/quality control (QA/QC) and environmental testing as they are easy to use, flexible, affordable, and scalable.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243898303

Geographical Regions Mapped in Report:

On the basis of region, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the UV/visible spectroscopy market. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period and serve as a revenue pocket for companies offering UV/visible spectroscopy systems and accessories. This is owing to the impetus provided by entry of key market players into this market, growing food safety and environmental pollution concerns and budding life science R&D sector in this region.

Maior Key Players Mapped in Research Report:

The major players in UV/visible spectroscopy market include Shimadzu Corporation (Japan), PerkinElmer Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies Inc. (U.S.) and Hach Company (subsidiary of Danaher Corporation) (U.S.).

UV/Visible Spectroscopy Market Analysis, Geographical Segmentation, Drivers, Challenges, Forecast Report

The UV/Visible Spectroscopy Market is poised to reach USD 1,163.2 Million, growing at a CAGR of 4.3 % during the forecast period, analyzes and studies the major market drivers, restraints/challenges, and opportunities.

 

Growing opportunities in emerging nations, development of micro volume sampling-capable instruments, investments into the field of molecular diagnostics and growth of biobanking are likely to provide growth opportunities to the global UV/visible spectroscopy market. However, the dearth of skilled professionals and longevity of instruments is likely to restrain the growth of this market.

 

Major Growth Drivers:

 

  • – Applications of UV/Visible Spectroscopy in Environmental Screening
  • – Growing Use of UV/Visible Spectroscopy in the Pharmaceuticals & Biotechnology Industry
  • – Technological Advancement
  • – Increasing Need for Food Analysis

Browse 80 market data tables and 43 figures spread through 150 pages and in-depth TOC – Request Research Sample Pages: 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=243898303

 

Market Segmentation in Depth:

 

Based on instrument type, the market is segmented into single-beam systems, dual-beam systems, array-based systems and handheld systems. The single-beam systems segment is estimated to account for the major share of the UV/visible spectroscopy market. These instruments are routinely used analytical instruments in clinical examination, medicine, petrochemicals, biochemistry, biotechnology, quality control, and environmental protection as they are simple and economical.

 

Based on application, the market is segmented into academic applications and industrial applications. The industrial applications segment is estimated to account for the major share of the UV/visible spectroscopy market. The instruments are used in various industrial fields such as life science R&D, production, quality assurance/quality control (QA/QC) and environmental testing as they are easy to use, flexible, affordable, and scalable.

 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243898303

 

Geographical Regions Mapped in Report:

 

On the basis of region, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the UV/visible spectroscopy market. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period and serve as a revenue pocket for companies offering UV/visible spectroscopy systems and accessories. This is owing to the impetus provided by entry of key market players into this market, growing food safety and environmental pollution concerns and budding life science R&D sector in this region.

 

Maior Key Players Mapped in Research Report:

 

The major players in UV/visible spectroscopy market include Shimadzu Corporation (Japan), PerkinElmer Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies Inc. (U.S.) and Hach Company (subsidiary of Danaher Corporation) (U.S.).

Original post:
roberthenric.booklikes.com/post/1933394/uv-visible-spectroscopy-market-analysis-geographical-segmentation-drivers-challenges-forecast-report

Body Composition Analyzers Market | Geographical Growth | Opportunities | Key Players

The Body Composition Analyzers Market is poised to reach USD 668.16 Million, growing at a CAGR of 12.7% during the forecast period.

Body composition analysis is the process to evaluate the amount of fat, muscle, and bone in the body. It gives the precise measurement of body fat in relation to lean body mass. Evaluation of body composition is essential in order to determine the risks associated with high or low levels of body fat. The growth of the overall body composition analyzers market can be contributed to rise in obese population across the globe, growing health and fitness consciousness among people, increasing government initiatives to encourage physical activity and technological advancements.

Objectives of the Study

  • To define, describe, and forecast the global body composition analyzers market on the basis of product, end user, and region
  • To provide detailed information regarding major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

Browse 71 market data tables and 30 figures spread through 116 pages and in-depth TOC – Request Research Sample Pages:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=248209133

Body Composition Analyzers MarketBody Composition Analyzers Market
Body Composition Analyzers Market

Market Segmentation in Depth:

Based on product, the market is segmented into bio-impedance analyzer, dual energy X-ray absorptiometry (DEXA), skin fold Calipers, air displacement plethysmography (ADP) and hydrostatic weighing. The bio-impedance analyzer is expected to account for the largest share of the body composition analyzers market, by product and is expected to grow at highest CAGR. This large share can be attributed to the simplicity, low cost, and better accuracy as compared to other body composition analyzers.

Based on end users, the market is segmented into hospitals, fitness clubs and wellness centers, academic and research centers. In 2016, hospitals segment is estimated to account for the largest share of the body composition analyzer market, by end users and is expected to grow at highest CAGR. The growth of this segment can be attributed to the rise in osteoporosis cases, increasing adoption of body composition analyzers to assess the nutritional status in patients and increasing health consciousness among masses.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=248209133

Geographical Regions Mapped in Report:

On the basis of region, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the body composition analyzer market. Its large share can be attributed to rising obesity rates and increasing health clubs and fitness centers in the U.S. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period due to rising trend of overweight and obesity in China, and foothold of local players in Japan.

Maior Key Players Mapped in Research Report:

The major players in body composition analyzers market include InBody Co., Ltd (South Korea), Tanita Corporation (Japan), Omron Corporation (Japan), Hologic, Inc. (U.S.) and GE Healthcare (U.S.) among others.

Fractional Flow Reserve Market with Huge Growth Opportunities, Competitive Landscape, Industry Analysis, CAGR Status

Growth in this market is primarily attributed to the rising geriatric population and the subsequent increase in the prevalence of cardiovascular diseases, cost benefits of FFR, and the presence of a favorable reimbursement scenario for FFR.

 

[105 Pages Report] The fractional flow reserve market is projected to reach USD 1,082 million by 2024 from USD 516 million in 2019, at a CAGR of 16.0% during the forecast period.

 

Market Dynamics:

 

Driver: Rising geriatric population and the subsequent growth in the prevalence of CVD;

 

Over the years, there has been a significant increase in the geriatric population across the globe. According to the UN World Population Ageing Report 2017, the global geriatric population (aged 60 years and above) is expected to reach 2.1 billion by 2050 from 962 million in 2017.

 

As this population segment is highly susceptible to CVD and other target diseases, the demand for advanced diagnostic and treatment options is expected to increase in the coming years. Changing lifestyle, smoking, hypertension, high blood cholesterol levels, physical inactivity, high BMI, and high blood sugar levels are the leading risk factors for heart disease and stroke. With the rising prevalence of CVD, the number of related diagnostic and treatment procedures is expected to increase significantly across the globe in the coming years. In this scenario, the demand for fractional flow reserve is likely to increase as it provides various benefits, such as assessing if the stenosis is required, which in turn helps in avoiding surgeries (in cases where stenosis is not needed).

 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=257837023

 

Report Objectives in Detailed:

 

  • To define, describe, and forecast the fractional flow reserve market by technology, application, and region
  • To provide detailed information regarding factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

 

Market Segmentation in Depth:

 

By technology, the invasive monitoring segment is estimated to hold the largest share of the fractional flow reserve market

 

Based on technology, the fractional flow reserve market is segmented into invasive and non-invasive monitoring. The invasive monitoring segment accounted for the largest share of the market in 2018. The large share of this segment can be attributed to the strong recommendation for FFR usage in coronary angiography by the American College of Cardiology, American Heart Association, European Society of Cardiology (ESC), and the European Association for Cardio-Thoracic Surgery (EACTS).

 

Pressure Guidewires to dominate fractional flow reserve market during the forecast period

 

On the basis of type, the invasive monitoring market is segmented into pressure guidewires and FFR monitoring systems. The pressure guidewires segment accounted for the larger market share in 2018. This can be attributed to the growth in the number of PCI procedures (as a result of the rising prevalence of CVD), strong recommendation for guided revascularization by measuring FFR in specific clinical scenarios, and the single-use nature of pressure guidewires.

 

Request Research Sample Pages: 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=257837023

 

North America is expected to hold the largest market share during the forecast period

 

North America is the major revenue-generating region in the fractional flow reserve market. The fractional flow reserve market in the region is driven by high healthcare spending in the region, rising prevalence of CVD and lifestyle diseases, growth in the geriatric population, a large number of ongoing research activities and product launches, availability of reimbursements, and the rapid adoption of technologically advanced imaging systems.

 

Key Market Players

 

The key players in the fractional flow reserve industry are Abbott (US), Boston Scientific (US), ACIST Medical Systems (US), Koninklijke Philips N.V. (Netherlands), Opsens, Inc. (Canada), HeartFlow, Inc. (US), Siemens Healthineers (Germany), Pie Medical Imaging (Netherlands), CathWorks (Israel), and Medis Medical Imaging Systems BV (Netherlands)

Source:
www.marketsandmarkets.com/Market-Reports/fractional-flow-reserve-market-257837023.html

Original post:
roberthenric.booklikes.com/post/1971564/fractional-flow-reserve-market

Pen Needles Market | Geographical Growth | Opportunities | Key Players

The Pen Needles Market is expected to reach $1.8 billion by 2024 from an estimated $1.1 billion in 2019, at a CAGR of 10.8% during the forecast period.

The study involved four major activities in estimating the current market size for pen needles. Exhaustive secondary research was done to collect information about the market, peer markets, and the parent market. The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research.

Secondary Research:

In the secondary research process, various secondary sources such as the WHO, International Diabetes Federation, World Bank, Global Burden of Disease Study, Food and Drug Administration, American Diabetes Association, American Association of Diabetes Educators, Centers for Disease Control and Prevention, Diabetes Canada, Statistics Canada, European Association for the Study of Diabetes, European Society of Endocrinology, Diabetes UK, National Health Service, OECD Health Statistics, Asian Association for the Study of Diabetes, ASEAN Federation of Endocrine Societies.

Primary Research:

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the pen needles market.

Download PDF (Please share your specific interest to serve you better.): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=75948613

pen-needles-market7

Market Segmentation:

On the basis of therapy, the pen needles market is segmented into insulin, GLP-1, growth hormone, and other therapies such as osteoporosis, fertility, and obesity. The insulin therapy segment is expected to grow at a higher CAGR during the forecast period primarily due to the high and growing diabetic population globally. Since pen needles need to be replaced after every injection, the rising use of insulin pens is a major factor driving the demand for pen needles. Additionally, favorable reimbursement scenario for pen needles in several North American, European, and Asian countries is the other major factor driving the demand for pen needles.

On the basis of length, the market is segmented into 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm. In 2018, the 8mm segment accounted for the largest share of the pen needles market. Growth in this market is largely driven by the high adoption of these needles among diabetes patients. However, the usage of these needles is likely to witness a decrease in the coming years due to the increased usage of shorter needles that cause less pain and enable easy insulin administration

Recent Developments:

  • In 2018, Becton, Dickinson and Company (US) launched its BD Ultra-Fine micro pen needle 6mm x 32G in the market.
  • In 2016, Ypsomed (Switzerland) entered into an agreement with Tonghua Dongbao Pharmaceutical (China) with an aim to distribute its mylife Clickfine pen needles in China.
  • In 2015, Ypsomed (Switzerland) launched mylife Clickfine DiamondTip pen needles.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=75948613

Geographical Analysis:

  • A further breakdown of the Rest of Asia Pacific CRT market into South Korea, New Zealand, and other South East Asian countries
  • A further breakdown of the European CRT market into Belgium, Netherlands, and Rest of Europe.

North America is expected to dominate the market in 2018. The large share of the North American market can primarily be attributed growing diabetes prevalence and favorable reimbursement scenario for pen needles, federal initiatives to create awareness about injection techniques, increasing market penetration by leading players, and the development of improved pen needle technologies.

The key players in the pen needles market are Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), HTL-STREFA S.A. (Poland), Terumo Corporation (Japan), and Owen Mumford (UK).

Medical Supplies Market |Geographical Growth|Opportunities|Key Players

The Global Medical Supplies Market is projected to grow from USD 133.5 billion by 2025 from USD 132.6 billion in 2020, at a CAGR of 4.6%.

Market Size Estimation;

Both top-down and bottom-up approaches were used to estimate and validate the total size of the medical supplies market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation;

After arriving at the overall medical supplies market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the medical supplies industry.

Browse 126 market data Tables and 45 Figures spread through 227 Pages and in-depth TOC – Request Research Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=64344238

medical-supplies-market3

Market Segmentation in Depth:

By type, the medical supplies market is segmented into diagnostic supplies, infusion & injectable supplies, intubation & ventilation supplies, disinfectants, personal protective equipment, sterilization consumables, wound care consumables, dialysis consumables, radiology consumables, catheters, sleep apnea consumables, and other medical supplies. The intubation & ventilation supplies segment is expected to grow at the highest growth rate during the forecast period. The growth of this segment is driven mainly by the rising prevalence of respiratory diseases such as asthma and COPD across the globe.

The applications market is categorized into urology, wound care, radiology, respiratory, infection control, cardiology, IVD, and other applications. The other applications segment held the largest market share in 2019, due to factors such as the increasing number of surgical procedures, rising prevalence of dental diseases, and the increasing focus on adhering to proper waste disposal methods.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64344238

Geographical Analysis in Detailed:

The global medical supplies market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest market share, followed by Europe. The increasing incidence of COVID-19 in the US and the implementation of various supportive initiatives by the Canadian Government are the major factors driving the growth of the medical supplies market in North America.

Major Key Players:

The prominent players operating in the global medical supplies market include Medtronic (Ireland), Cardinal Health, Inc. (US), BD (US), Johnson & Johnson (US), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), Thermo Fisher Scientific, Inc. (US), Baxter International, Inc. (US), Avanos Medical, Inc. (US), 3M (US), Smith & Nephew (Ireland), ConvaTec Group Plc. (UK), Abbott (US), Cook Medical (US), Merit Medical Systems (US), Stryker (US), Terumo Corporation (Japan), Teleflex Incorporated (US), Fresenius Medical Care AG & Co. KGaA (Germany), and Coloplast Group (Denmark).

4 thoughts on Lancets Market Overview | Growth Drivers | Restraints | Opportunities, and Trends | Insights by Geography | Competitive Landscape

[107 Pages Report] The Lancets Market is projected to reach USD 1,442 million by 2024 from USD 804 million in 2019, at a CAGR of 12.4% between 2019 and 2024.

Growth in the lancets market is mainly driven by the growing prevalence of diabetes and the high prevalence of infectious diseases across the globe. In addition, emerging markets such as India and China are expected to offer growth opportunities for players operating in the lancets market during the forecast period. However, the risk of needlestick injuries, the reuse of lancets, and the poor reimbursement scenario in developing countries are restricting the growth of this market.

Market Size Estimation;

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by type, application, end user, and region).

Data Triangulation;

After arriving at the market size, the lancets market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments.

Browse 75 market data Tables and 27 Figures spread through 107 Pages and in-depth TOC – Request Research Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=86063487

lancets-market1

Market Segmentation in detailed:

Safety Lancet is expected to be the most widely used type of the lancets market

The safety lancets accounted for the largest market share in 2018. This is primarily be attributed to the advantages associated with safety lancets such as their ease of use, the capability to prevent needlestick injuries and cross-contamination, and painlessness of vein puncture. In line with this, According to PharmaJet, in the US, around 600,000 to 800,000 needlestick injuries are reported every year. This is expected to increase the demand of safety lancets.

Glucose testing segment is expected to account for the largest share of the lancets market application

The glucose testing segment accounted for the largest share of the lancets market, by application, in 2018. This is primarily due to the increasing prevalence of diabetes, and the need for its prevention and management. For instance, according to the International Diabetes Federation (IDF), in 2017, there were almost 425 million people suffering from diabetes worldwide, and this figure is expected to increase to 629 million by 2045. The growing prevalence of diabetes has resulted in the increased adoption of lancets to effectively handle the growing patient pool.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=86063487

Which are the Key players operating in lancets Market?

The global lancets market is highly competitive, owing to the presence of several large and small players. Becton, Dickinson And Company (US), Roche Diagnostics (Switzerland), Ypsomed (Switzerland), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Own Mumford (UK), HTL-STREFA S.A (Poland), ARKRAY (Japan), Sarstedt (Germany), and SteriLance Medical (Suzhou) (China).

Major Insights on Lancets Market – Global Growth Opportunities

The Lancets Market is projected to reach USD 1,442 million by 2024 from USD 804 million in 2019, at a CAGR of 12.4% between 2019 and 2024.

 

Growth in the lancets market is mainly driven by the growing prevalence of diabetes and the high prevalence of infectious diseases across the globe. In addition, emerging markets such as India and China are expected to offer growth opportunities for players operating in the lancets market during the forecast period. However, the risk of needlestick injuries, the reuse of lancets, and the poor reimbursement scenario in developing countries are restricting the growth of this market.

 

Market Size Estimation;

 

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by type, application, end user, and region).

 

Data Triangulation;

After arriving at the market size, the lancets market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments.

 

Browse 75 market data Tables and 27 Figures spread through 107 Pages and in-depth TOC – Request Research Sample Pages: 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=86063487

 

Market Segmentation in detailed:

 

Safety Lancet is expected to be the most widely used type of the lancets market

 

The safety lancets accounted for the largest market share in 2018. This is primarily be attributed to the advantages associated with safety lancets such as their ease of use, the capability to prevent needlestick injuries and cross-contamination, and painlessness of vein puncture. In line with this, According to PharmaJet, in the US, around 600,000 to 800,000 needlestick injuries are reported every year. This is expected to increase the demand of safety lancets.

 

Glucose testing segment is expected to account for the largest share of the lancets market application

 

The glucose testing segment accounted for the largest share of the lancets market, by application, in 2018. This is primarily due to the increasing prevalence of diabetes, and the need for its prevention and management. For instance, according to the International Diabetes Federation (IDF), in 2017, there were almost 425 million people suffering from diabetes worldwide, and this figure is expected to increase to 629 million by 2045. The growing prevalence of diabetes has resulted in the increased adoption of lancets to effectively handle the growing patient pool.

 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=86063487

 

Which are the Key players operating in lancets Market?

 

The global lancets market is highly competitive, owing to the presence of several large and small players. Becton, Dickinson And Company (US), Roche Diagnostics (Switzerland), Ypsomed (Switzerland), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Own Mumford (UK), HTL-STREFA S.A (Poland), ARKRAY (Japan), Sarstedt (Germany), and SteriLance Medical (Suzhou) (China).
 

Which is the dominating region in lancets market?

 

North America is expected to hold the largest share of the global lancets market in 2019, followed by Europe. Factors such as increasing prevalence of diabetes and favorable reimbursement scenario in the region are driving the North American lancets market growth. Asia Pacific is expected to record the highest CAGR in the forecast period, due to rapid economic growth, and raising awareness about diabetes treatment.

Original post:
roberthenric.booklikes.com/post/1918852/major-insights-on-lancets-market-global-growth-opportunities

Protein Crystallization and Crystallography Market – Segmentation, Major Players & Geographical Analysis

The Global Protein Crystallization and Crystallography Market size is projected to reach USD 1.7 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 8.9% during the forecast period.

Market Size Estimation;

For calculating the global market value, segmental revenues were arrived at based on the revenue mapping of major players active in the protein crystallization  market. This process involved the following steps:

  • Generating a list of the major global players operating in the market
  • Mapping the annual revenues generated by 1-2 public companies from the protein crystallography market (or the nearest reported business unit/product/ service category)
  • Estimating the revenue from the related market and extrapolating the global number as of 2019
  • Calculating 100% of the global market value of the protein crystallization and crystallography market
  • The market was also validated through a technology-based approach

Data Triangulation;

After arriving at the overall market size using the market size estimation processes explained above, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides of the protein crystallization market.

Browse 142 market data Tables and 30 Figures spread through 147 Pages and in-depth TOC – Request Research Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=147057058

Protein Crystallization and Crystallography Market
Protein Crystallization and Crystallography Market

Market Segmentation in Depth:

By product and service, the consumables segment accounted for the largest market share in 2019.

On the basis of product and service, the consumables segment accounted for the largest share of the protein crystallization market in 2019. This can be attributed to a large number of reagent kits and microplates used in proteomics research and the increasing demand for miniature screening plates in automated liquid handlers.

By end user, the pharmaceutical companies segment accounted for the largest market share in 2019.

The pharmaceutical companies segment accounted for the largest share of the protein crystallography market in 2019. This can be attributed to the increasing demand for protein-based drugs and the increasing demand for biologics in various application areas.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=147057058

North America dominates the protein crystallization and crystallography market.

The protein crystallography market is divided into five major regions, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2019, North America accounted for the largest share of the global market, followed by Europe. The growth in this market can be attributed to the increasing investments in the development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, and the rising demand for high-quality research tools.

Key Market Players

The major companies in the protein crystallization and crystallography market are Rigaku Corporation (Japan), Hampton Research (US), Jena Bioscience GmbH (Germany), and Bruker Corporation (US).

Blog at WordPress.com.

Up ↑

Create your website at WordPress.com
Get started